Cargando…
Monoclonal antibodies — a proven and rapidly expanding therapeutic modality for human diseases
The study of antibodies has been a focal point in modern biology and medicine since the early 1900s. However, progress in therapeutic antibody development was slow and intermittent until recently. The first antibody therapy, murine-derived murononab OKT3 for acute organ rejection, was approved by th...
Autor principal: | An, Zhiqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Higher Education Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4875100/ https://www.ncbi.nlm.nih.gov/pubmed/21203944 http://dx.doi.org/10.1007/s13238-010-0052-8 |
Ejemplares similares
-
Therapeutic Applications of Monoclonal Antibodies
por: Berger, Mitchell, et al.
Publicado: (2002) -
Monoclonal Antibodies as Neurological Therapeutics
por: Gklinos, Panagiotis, et al.
Publicado: (2021) -
Human monoclonal antibodies as candidate therapeutics against emerging viruses
por: Jin, Yujia, et al.
Publicado: (2017) -
Human Monoclonal Antibodies: On the Menu of Targeted Therapeutics Against COVID-19
por: Chen, Junsen, et al.
Publicado: (2021) -
Expanding the Reach of Monoclonal Antibodies: A Review of Synthetic Nucleic Acid Delivery in Immunotherapy
por: Chung, Christopher, et al.
Publicado: (2023)